BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12718871)

  • 1. Nuclear receptor ligands and cofactor recruitment: is there a coactivator "on deck"?
    Nettles KW; Greene GL
    Mol Cell; 2003 Apr; 11(4):850-1. PubMed ID: 12718871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor: from structure to potential clinical applications.
    Pellicciari R; Costantino G; Fiorucci S
    J Med Chem; 2005 Aug; 48(17):5383-403. PubMed ID: 16107136
    [No Abstract]   [Full Text] [Related]  

  • 3. Bile acids: natural ligands for an orphan nuclear receptor.
    Parks DJ; Blanchard SG; Bledsoe RK; Chandra G; Consler TG; Kliewer SA; Stimmel JB; Willson TM; Zavacki AM; Moore DD; Lehmann JM
    Science; 1999 May; 284(5418):1365-8. PubMed ID: 10334993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
    Wang H; Chen J; Hollister K; Sowers LC; Forman BM
    Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ; Kullak-Ublick GA
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling.
    Anisfeld AM; Kast-Woelbern HR; Lee H; Zhang Y; Lee FY; Edwards PA
    J Lipid Res; 2005 Mar; 46(3):458-68. PubMed ID: 15604525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
    Savkur RS; Thomas JS; Bramlett KS; Gao Y; Michael LF; Burris TP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):170-8. PubMed ID: 15329387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXR, a therapeutic target for bile acid and lipid disorders.
    Westin S; Heyman RA; Martin R
    Mini Rev Med Chem; 2005 Aug; 5(8):719-27. PubMed ID: 16101408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a nuclear receptor for bile acids.
    Makishima M; Okamoto AY; Repa JJ; Tu H; Learned RM; Luk A; Hull MV; Lustig KD; Mangelsdorf DJ; Shan B
    Science; 1999 May; 284(5418):1362-5. PubMed ID: 10334992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR signaling in metabolic disease.
    Zhang Y; Edwards PA
    FEBS Lett; 2008 Jan; 582(1):10-8. PubMed ID: 18023284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity.
    Gineste R; Sirvent A; Paumelle R; Helleboid S; Aquilina A; Darteil R; Hum DW; Fruchart JC; Staels B
    Mol Endocrinol; 2008 Nov; 22(11):2433-47. PubMed ID: 18755856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR, a target for different diseases.
    Wang YD; Chen WD; Huang W
    Histol Histopathol; 2008 May; 23(5):621-7. PubMed ID: 18283647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.
    Kuipers F; Claudel T; Sturm E; Staels B
    Rev Endocr Metab Disord; 2004 Dec; 5(4):319-26. PubMed ID: 15486464
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.